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Aims To investigate how variability in activation sequence and passive conduction properties translates into clinical vari-





Multiscale bidomain simulations using a detailed heart-torso human anatomical model are performed to investigate
the impact of activation sequence characteristics on clinical QRS biomarkers. Activation sequences are built and
validated against experimentally-derived ex vivo and in vivo human activation data. R-peak amplitude exhibits the
largest variability in terms of QRS morphology, due to its simultaneous modulation by activation sequence speed,
myocardial intracellular and extracellular conductivities, and propagation through the human torso. QRS width,
however, is regulated by endocardial activation speed and intracellular myocardial conductivities, whereas QR
intervals are only affected by the endocardial activation profile. Variability in the apico-basal location of activation
sites on the anterior and posterior left ventricular wall is associated with S-wave progression in limb and precordial
leads, respectively, and occasional notched QRS complexes in precordial derivations. Variability in the number of
early activation sites successfully reproduces pathological abnormalities of the human conduction system in the
QRS complex.
...................................................................................................................................................................................................
Conclusion Variability in activation sequence and passive conduction properties captures and explains a large part of the clinical
variability observed in the human QRS complex. Our physiological insights allow for a deeper interpretation of
human QRS biomarkers in terms of QRS morphology and location of early endocardial activation sites. This might
be used to attain a better patient-specific knowledge of activation sequence from routine body-surface
electrocardiograms.
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Introduction
Since its invention by Einthoven at the beginning of the 20th century,
the body-surface electrocardiogram (ECG) remains as the most ex-
tensively used clinical tool for the non-invasive diagnosis of cardiac
disorders. A specific challenge is to discriminate between the effects
on the ECG biomarkers of the different components of the ventricu-
lar activation and repolarization sequences (involving simultaneous
transmural, apico-basal, posterior-anterior, and inter-ventricular
propagation), and/or the contribution of concurrent pathological
states. This hampers our ability to effectively extract the maximum
information about the heart from the ECG.
In this context, multiscale human heart models are powerful plat-
forms to integrate electrophysiological and structural information
from the ionic to the whole organ levels, and to differentiate between
key factors determining ECG biomarkers in disease1 or under
pharmacological action.2 Such an improved knowledge may further
aid in the development of more selective biomarkers for specific dis-
eased conditions or drug-induced risk stratification.3 Most computa-
tional studies to date, however, have mainly concentrated on
replicating the repolarization sequence of the human ventricles and
placed less attention on the activation sequence, often resulting in
poorly-recovered QRS complex morphology and lead polarities (see
for example1,2) This highlights the need for accurate representations
of the human activation sequence in ECG simulations, due to its dir-
ect influence in determining repolarization, and to properly address
the computational study of cardiac conduction disorders.
In this work, we investigate the effect of variability in characteristics
of the human ventricular activation sequence in the simulated QRS
complex using a human torso-heart bidomain model. The simulated ac-
tivation sequences are built and validated using experimentally-derived
human activation data, ranging from ex vivo microelectrode recordings,
non-invasive in vivo electromechanical wave and electrocardiographic
imaging, up to the body-surface ECG. Quantitative investigations on
variability in activation sequence and passive conduction properties are
then presented to gain novel insights on the impact of tissue-level
propagation in clinical QRS biomarkers, as well as to demonstrate the
feasibility of our approach to model pathophysiology of the human
conduction system. Our results can therefore have important implica-
tions in advancing the realistic modelling of cardiac conduction under
healthy and diseased conditions, and aid in unravelling the role of vari-
ability in modulating response to therapy at the population level.
Methods
Experimental data
The present investigations build on three main sources of human experi-
mental data. Firstly, ventricular activation sequences were based on ex vivo
microelectrode recordings by Durrer et al.4 (Figure 1A), in vivo electro-
mechanical wave imaging by Provost et al.5 (Figure 1B), and in vivo epicar-
dial activation sequences as reported by Ramanathan et al.6 through
non-invasive electrocardiographic imaging (Figure 1C). Secondly, distribu-
tions of body-surface potentials (BSPs) during ventricular activation in
healthy conditions were analysed from Taccardi et al.7 (Figure 1D).
Thirdly, 12-lead body-surface ECG signals (Figure 1E) in healthy and bundle
branch block conditions were obtained from the PTB Diagnostic ECG
Database,8 freely available in Physionet (www.physionet.org), whilst
hemiblock ECGs (not present in the PTB Diagnostic ECG Database)
were analysed from Elizari et al.9
Anatomical heart-torso model
A human biventricular mesh, embedded in a torso volume containing
lung and bone regions, was generated from computer tomography
images as described in Supplementary Methods. Virtual electrodes were
positioned on the torso at standard electrode locations for the calcula-
tion of the 12-lead ECG (Supplementary material online, Figure S1).
Electrophysiological and tissue model
Computer simulations were conducted using the fully coupled heart-
torso bidomain equations, which are the gold-standard for the descrip-
tion of cardiac electrical propagation, including detailed description of
human ventricular cellular electrophysiology. Myocardial and torso con-
ductivities were based on the literature, as detailed in Supplementary
Methods, together with specifications on our numerical solver. Research
materials are available upon request.
Activation system models
As in Keller et al.10 and due to the variability and lack of high-resolution
data on which to build anatomically-detailed models of the human free-
running Purkinje network, we assume that its branches couple with and ex-
cite the endocardial layer at several sites of earliest activation (root
points) from which excitation quickly progresses. We base the positions
of these root points on the notion of the human trifascicular conduction
system11 (left anterior-superior, left posterior-inferior and right lateral
fascicular branches). To model the tightly-packed endocardial Purkinje net-
work, pairwise distances between all endocardial surface nodes were pre-
processed using Dijkstra’s algorithm. At runtime, each endocardial sur-
face node is assigned a stimulus time proportional to the distance to its
closest root node. The constant of proportionality allows a straightfor-
ward control of conduction velocity in the abstracted endocardial
Purkinje network. This was adjusted to yield a distribution of endocardial
What’s New?
• Multiscale human heart-torso models with anatomical and
functional detail based on multimodal human activation data
are presented for investigations on variability in clinical QRS
biomarkers.
• Activation sequence, myocardial conductivities and torso
propagation have distinct effects in modulating R-peak ampli-
tude, QRS width and QR interval.
• Variability in the anatomical location of left ventricular activa-
tion sites is associated with S-wave progression in limb and
precordial leads, and notched QRS complexes in precordial
derivations.
• Variability in the number of early activation sites replicates the
clinical QRS manifestations of all hemiblocks and bundle
branch blocks of the human conduction system.
• The tools presented here advance the field of computational
cardiac electrophysiology towards more predictive technolo-
gies for risk assessment at the population level, as well as
for the better understanding of clinical ECG biomarkers of
disease.
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Figure 1 Non-diseased human ventricular activation data considered in this study. (A) Ex vivo microelectrode recordings of activation sequence in
a healthy subject. (B) Non-invasive in vivo electromechanic wave imaging isochrones of three normal subjects. Arrows indicate ventricular sites of
early activation. (C) Non-invasive in vivo electrocardiographic imaging reconstruction of epicardial activation sequence in three healthy subjects.
(D) Body surface potential maps in a healthy subject during progression of ventricular activation. (E) QRS complexes in the 12-lead ECG of a repre-
sentative healthy individuals of the PTB Diagnostic ECG Database8 (subject 198). Clinical ECG grid resolution: 40 ms/0.1 mV. Panels A–D reproduced
with permission from Durrer et al.,4 Provost et al.,5 Ramanathan et al.6 and Taccardi,7 respectively.
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activation times in accordance with the reported ex vivo microelectrode
recordings by Durrer et al.4
Results
Model construction and validation
Human ventricular activation data exhibit a high level of inter-subject
variability in the sites of earliest activation and epicardial break-
through, as illustrated in the multi-modality data comparison
summarized in Figure 1. The following commonalities were however,
identified across the studied human datasets: (i) activation within the
left ventricle (LV) usually begins on the basal anterior paraseptal, the
mid-septum and the posterior apex regions, and then progresses
transmurally (Figure 1A and B); (ii) earliest activation in the free wall of
the right ventricle (RV) occurs ‘near the insertion of the anterior pap-
illary muscle’,4 the position of which is known to be highly variable
(Figure 1B and C); and (iii) activation of the RV epicardium usually
occurs before that of the LV epicardium (Figure 1B and C).
Based on the above, we designed a baseline configuration of the
human activation sequence (see Figure 2A, black arrows) consisting of
four LV earliest activation sites (LV mid septum, LV basal anterior
paraseptal, and two LV mid-posterior) and three in the RV (RV mid
septum, two RV free wall). Such a configuration allows for a multi-
scale investigation (up to the body-surface ECG) of inter-subject vari-
ability in activation speed and passive tissue conductivities, as well as
in the position and number of earliest activation sites, without favour-
ing a specific data modality in our analysis.
Simulated ventricular activation times for the baseline configur-
ation are presented in Figure 2A. The LV endocardial surface is fully
activated within 30 ms, transmural propagation occurs in 35 ms in the
LV basal free wall, with transseptal propagation of 25 ms. This is in ac-
cordance with the ex vivo microelectrode recordings by Durrer et al.4
(Figure 1A), reporting 35 ms in endocardial LV activation, and 25 and
35 ms in transseptal and transmural propagation, respectively. Slightly
shorter activation times are obtained in the RV base in simulations,
possibly due to uncertainties in the atria-ventricular segmentation.
Cross-sectional slices of ventricular activation times are shown in
Figure 2B for comparison with in vivo electromechanical wave imaging
data by Provost et al.5 (Figure 1B), indicating agreement in the location
of earliest and latest activation sites. Specifically, early activation
occurred on either side of the septum, RV free wall, and anterior and
posterior LV paraseptal sites. Latest activation took place in the basal
septum, basal lateral LV wall, and apex.
Anterior and posterior views of epicardial activation times are pro-
vided in Figure 2C for ease of comparison with the in vivo electrocar-
diographic imaging data of Ramanathan et al.6 Simulation results are in
close agreement with Subjects 1 and 3 in Figure 1C, with earliest
breakthrough in the upper paraseptal anterior RV, apical LV activa-
tion 20 ms later, and basal LV activation 28 ms after that. The activa-
tion of the RV epicardium completed in 30 ms, compared to 25 ms in
healthy subjects. The LV epicardial breakthrough occurred about
15 ms after the RV breakthrough, consistent with both Subjects 1
and 3. The pattern of LV epicardial activation is well reproduced due
to the lateral basal LV root point (leading to the epicardial break-
through on the LV anterior paraseptal region) and the thickening of
the LV free wall from apex to base (which generates activation times
that lengthen from apex to base).
Figure 2D shows isopotential maps of BSPs, exhibiting the same
spatiotemporal evolution during ventricular activation as those re-
ported in healthy subjects by Taccardi et al.7 (Figure 1D). Initially a
local maximum appears on the chest due to the first RV epicardial
breakthrough (10 ms). Once the activation of the RV is completed,
this is replaced by a negative region. The positive pole moves left-
wards and downwards as activation progresses transmurally through
the LV. This forms the characteristic dipole pattern on the front of
the chest with a zero isopotential between the lower-right flank and
the left shoulder (20–30 ms). The maximum is finally drawn towards
the latest area to activate, the posterior paraseptal LV (40 ms).
As a consequence of the distributions of BSPs described above, a
frontal plane QRS axis (average of global ventricular depolarization)
between30 andþ90 is considered to be normal, where 0 is left-
wards in the transverse plane. This determines the limb (I, II, III) and
augmented (aVR, aVL, aVF) leads, and yields negative precordial leads
in V1, positive in V4–V6, with R-wave progression in between, as
illustrated in Figure 1E for a representative healthy subject. For com-
parison, Figure 2E illustrates the simulated QRS complexes associated
with our baseline activation sequence, exhibiting a QRS width of
70 ms within the normal range (60–100 ms) and a QRS axis of 60,
both within the healthy range, and typical lead polarities in all limb,
augmented limb and precordial leads, as well as R-wave progression
in the latter.
Variability in subendocardial activation
speed and myocardial conductivities
modulate QRS width and amplitude
Detailed simulation studies were conducted to investigate how vari-
ability in the different determinants of distributions of BSPs modu-
lates the human QRS complex. Whilst the extent of this variability in
the human population is difficult to determine,12 we hypothesize that
variability of650% in activation sequence and tissue properties en-
capsulates a major fraction of the observed clinical variability in the
healthy human QRS complex. Changes on baseline QRS biomarkers
are hence presented in the following sections (averages reported
across all leads) for these bounds of plausible physiological variability.
In fact, this could be a modest estimate of total variability across the
population, since variability bounds from 2 to 12-fold have been re-
ported in tissue conductivities in human,13 including blood (2.3),
lungs (3.4), fat (5.5), soft muscle (7.5), heart (9.0) and bone
(12).
Variability in endocardial activation speed directly impacts the full
ventricular activation sequence (Figure 3A, left panel), affecting the
width and amplitude of the reconstructed QRS complexes. Increased
activation speeds (Figure 3A, solid red traces) resulted in earlier R-
wave times-to-peak, shorter QRS widths, and increased R-wave
amplitudes (75 6 3%, 906 4%, and 125 6 30% of baseline, respect-
ively). Decreased activation speeds had the opposite effects (Figure
3A, solid blue traces), exhibiting protracted R-wave times-to-peak,
wider QRS widths, together with decreased R-wave amplitudes
(1786 7%, 1826 12%, and 836 8% of baseline, respectively).
Variability in intracellular myocardial conductivities (as modelled
by globally scaled conductivity tensors) substantially influences the
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Figure 2 Simulation results of the healthy human ventricular activation sequence. (A) Volumetric isochrones of ventricular activation times.
Arrows indicate activation system root points. (B) Cross-sectional slices of ventricular activation times. Arrows indicate ventricular sites of early acti-
vation. (C) Anterior and posterior views of epicardial activation times. Different colour maps are shown in Panels A–C to facilitate the comparison
with experimental data in Figure 1. (D) Isopotential body surface potential maps during progression of ventricular activation. (E) QRS complexes in
the simulated 12-lead ECG. Simulated ECG grid resolution: 40 ms/0.1 mV.
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Figure 3 Variability in activation speed and myocardial conductivities modulate QRS width and amplitude. (A) Variability in activation speed
impacts the ventricular activation sequence, affecting R-wave times-to-peak, R-wave amplitudes, and QRS width. (B) Variability in intracellular
myocardial conductivities influences the transmural dispersion of ventricular activation times, yielding scaled R-wave amplitudes and wider and less-
symmetric QRS complexes under conditions of decreased intracellular coupling. (C) Variability in extracellular myocardial conductivity yields a scaling
effects on QRS amplitudes. In all cases, dashed grey ECG traces represent baseline conditions, whereas solid red and blue ECG traces represent con-
ditions of increased and decreased myocardial parameters, respectively. Simulated ECG grid resolutions: 40 ms/0.1 mV.
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transmural dispersion of ventricular activation times (Figure 3B, left
panel). This yielded a predominant scaling effect on R-wave ampli-
tudes (121 6 13% and 656 12% of baseline for increased/decreased
intracellular conductivities, respectively), with a smaller impact on
times to R-peak (95 6 3% and 1056 3%, respectively). Wider QRS
widths (1276 7%) and less symmetric QRS complexes were also
associated with conditions of decreased intracellular coupling, in par-
ticular in the precordial leads (Figure 3B, solid blue traces).
On the other hand, variability in extracellular myocardial conduc-
tivities has a purely scaling role on the QRS complex, with negligible
effects on the ventricular activation sequence (Figure 3C). Across all
leads, peak R-wave amplitudes were 696 6% and 183 6 25% of
baseline for a 50% increase and decrease in extracellular conductivity
tensors, respectively. Times to R-peak were within 2% in all cases,
with negligible changes to QRS widths.
The observed effects can be explained by recalling a simplified
core-conductor model of electrical propagation in myocardial
fibers,14 with extracellular potentials given by










where ue is the extracellular potential at time t and body surface
point x, ri and re are the intracellular and extracellular conductivities,
and the integral represents the sum of the contribution of all gradi-
ents in intracellular potentials (rui) in the volume of the heart (X),
weighted by their respective distances to the measure point (r).
Changes in activation speed therefore affect the time course of endo-
cardial and transmural gradients in intracellular potentials, hastening
or protracting ventricular depolarization as reflected in the QRS
width and times to R-peak, while their spatial distribution (more
spread gradients for larger activation speeds) impacts R-wave ampli-
tudes (Figure 3A). In contrast, variability in intracellular conductivities
under the imposition of the same endocardial activation sequence
only modulates the transmural propagation of intracellular potentials,
hence impacting the terminal part of the QRS complex with moder-
ate influence on times to R-peak, together with a proportional scaling
of extracellular potentials (Figure 3B). Correspondingly, extracellular
potentials are inversely proportional to extracellular conductivities,
modulating R-wave amplitudes with negligible effects on intracellular
gradients (Figure 3C). Changes in QRS width by myocardial conductiv-
ities can also be interpreted by considering the effective conductivity
tensor, rm¼ rire/(riþ re), and its impact on myocardial propagation
speed, given by the square root of the quotient between altered and
baseline effective conductivities. For our choice of tissue properties,
variations ofþ50% and 50% in intracellular conductivities, respect-
ively yield changes ofþ20% and 27.5% in transmural propagation
speed, yet only ofþ1.7% and 4.6% for equivalent variations in the
extracellular tensor, which therefore explains the minor contribution
of the latter to the width of the QRS complex.
Variability in body conductivities
modulates QRS amplitudes
Similar to the role of extracellular myocardial conductivities, variabil-
ity in body conductivities (torso/lungs/bones) exerted a scaling effect
on QRS amplitudes by affecting the magnitudes of BSPs. Results on
the effects of this variability in torso conductivity are illustrated in
Figure 4, as this exhibited the largest contribution in the human QRS
complex compared to lung and bone conductivities (Supplementary
material online, Figure S2).
Although the spatial patterns of BSPs remained mostly unaltered
under variations of body conduction properties, the larger diffusion
of extracellular potentials associated with larger conductivities
yielded BSPs with lower magnitudes at times for R-peak, whilst
Figure 4 Variability in body conductivities modulates QRS amplitudes. Differences in the diffusion of electrical potential across the human torso af-
fect the magnitudes of BSPs, without significantly altering their spatial pattern (left panel; BSP distributions shown at time for R-peak in lead II). This is
translated in inversely proportional QRS amplitudes to body conductivities, and increased R-wave progression (right panel). Dashed grey ECG traces:
baseline conditions; solid red and blue ECG traces: increased and decreased torso conductivity, respectively. Symbols indicate maximum wave ampli-
tudes under variability in torso conductivity (same colour code). Simulated ECG grid resolution: 40 ms/0.1 mV.
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smaller body conductivities accentuated the magnitude of the
observed gradients (Figure 4, left panel). This was thus translated in in-
versely proportional QRS amplitudes to body conductivities in all
leads (R-peak amplitudes of 926 6% and 112 6 10% of baseline for
increased/decreased torso conductivities, respectively). In the pre-
cordial leads, reduced body conductivities increased R-wave progres-
sion (Figure 4, solid blue traces), and vice versa.
Variability in location of endocardial root
points affects S-wave progression
Additional simulation studies were performed in order to evaluate
how anatomical variability in the location of endocardial activation
root points (at coupling sites of the free-running Purkinje system) im-
pacts the human QRS complex. Eight activation sequences were de-
signed based on the anatomical variability reported on the human
trifascicular system,9 as well as the early activation sites in the ex vivo
microelectrode studies by Durrer et al.4 and in vivo electromechanical
wave imaging by Provost et al.5 These included six activation se-
quences altering the position of LV anterior and posterior coupling
sites towards more apical and basal locations, and two for more ap-
ical and/or lateral RV bundle coupling sites.
Variability in the location of early activation on the anterior LV
wall, from more basal towards more apical positions (Figure 5A, top
to bottom), was associated with increasing S-wave progression in
the limb and augmented limb leads (Figure 5A, blue arrows). This
progression was especially marked in leads II, III and aVF, exhibiting
increasingly more negative S-waves. Variability in the apico-basal
location of the LV posterior wall site was similarly correlated with
increasing S-wave progression in precordial leads V5 and V6
(Figure 5B, red arrows), as these are the only electrodes with a
solid angle view of the LV posterior wall. Some of the activation
sequences also presented notched QRS complexes in precordial
and limb leads (Figure 5A and B, black arrows), as a consequence of
variability in the positions of simultaneous LV earliest epicardial
breakthroughs. Such QRS features were also observed in healthy
individuals of the PTB Diagnostic ECG Database, as shown in the
two ECG excerpts presented in Figure 5C. On the other hand, acti-
vation sequences with more apical and/or lateral RV sites led to
similar QRS morphologies compared to baseline (Supplementary
material online, Figure S3). Simultaneous variations of more than
one LV/RV coupling sites led to an additive effect of the above dis-
cussed contributions.
Knockout of root nodes reproduce QRS
phenotype caused by intraventricular
conduction defects
Due to their direct correspondence with the trifascicular activation
system, variability in the number of root nodes can be used to repro-
duce pathophysiology of the human conduction system. This is illus-
trated in Figures 6 and 7 for LV anterior/posterior hemiblocks and
complete LV/RV bundle branch blocks, respectively.
Knocking out the activation of the LV anterior wall (Figure 6A,
black circle) resulted in the late activation of the LV basal free
wall. While the negative pole on the chest was almost unvaried,
this late region caused the positive pole in BSPs to move up from
the left hip to the centre of the back, yielding a late QRS vector
mainly oriented from front to rear torso surfaces and slightly left-
wards and upwards. As a consequence, the reconstructed QRS
complex exhibits the clinical manifestations of a left anterior fasci-
cular block9 (LAFB; lower-right panel of Figure 6A): QRS width
smaller than 120 ms; left-deviated late QRS axis to 50; qR pat-
tern in aVL and RS/Rs patterns in leads II, III and aVF, with wave
amplitudes satisfying RII>RIII and SIII> SII; and delayed intrinsi-
coid deflection (time from Q to R peaks) in aVL of 42 ms, close to
the clinical threshold of 45 ms.
Similarly, the knockout of LV posterior wall activation (Figure 6B,
black circle) was associated with a delayed activation of the posterior
LV basal wall, severely affecting the time course and position of the
poles in BSPs on the chest. Such a distribution of BSPs recovered the
clinical phenotype of a left posterior fascicular block9 (LPFB; lower-
right panel of Figure 6B): QRS width smaller than 120 ms; right-
deviated late QRS axis to 100; Rs or RS patterns in leads I and aVL;
qR patterns in leads III and aVF; and S waves in all precordial leads,
with intrinsicoid deflection times in V6 (24 ms) and aVF (34 ms)
greater than in aVL (21 ms). The less-symmetric (trapezoidal-like)
morphology in the last deflection of the QRS complex of all limb and
augmented limb leads observed in the clinical recordings is also
recovered.
Finally, a complete knockout of both LV anterior and posterior
branches led to a lateral progression of LV activation, significantly
delaying septal to basal LV stimulation (Figure 7A). This retrieved the
characteristic signature of left bundle branch block (LBBB) in precor-
dial leads: QRS complex of at least 120 ms; marked QS pattern in V1;
and notched R-wave in lead V6. Similarly, the knockout of coupling
sites on the RV led to a lateral sequence of RV activation (Figure 7B),
yielding the manifestation of right bundle branch block (RBBB): QRS
duration of at least 120 ms; terminal R-wave in lead V1; slurred
S-waves in leads I and V6.
Discussion
This study presents a detailed investigation on how variability in the
main determinants of the human activation sequence and passive
myocardial and body conduction properties translates into variability
in clinical QRS biomarkers. Our approach tightly couples state-of-
the-art anatomically-based multiscale bidomain simulations of human
ventricular electrophysiology with ex vivo and in vivo human activation
data. This allows augmenting the information attainable from scarce
and limited experimental recordings in human (usually available for
only small numbers of subjects, of low-resolution, and highly variable
between individuals) and gaining novel physiological knowledge on
the information enclosed in the human QRS complex.
R-peak amplitudes exhibit the largest amount of variability, as
these are shown to be simultaneously modulated by endocardial
activation speed, and by myocardial intracellular and extracellular
conductivities. Variability in torso and organs conductivities shows
an impact on QRS magnitude, in agreement with the literature.13
On the contrary, QRS width was only regulated by activation
speed and intracellular myocardial conductivities, whereas intrin-
sicoid deflection (QR interval) is only affected by the endocardial
activation. In particular, there is a high impact in reducing the
activation sequence speed on QRS duration. These insights can be
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of clinical relevance in order to separate from the ECG the con-
tribution of these three factors, as well as to make progress
towards more personalized activation sequences in computa-
tional studies.
Variability in the anatomical locations of activation root sites (cor-
responding to the coupling of the LV fascicular bundles with the myo-
cardium) was associated with S-wave progression in the limb and
precordial leads, and occasional notched QRS complexes in the
Figure 5 Variability in the location of LV endocardial activation sites affects S-wave progression. (A) More apical coupling sites of the LV anterior
fascicular branch were associated with increasingly more negative S-waves in leads II, III and aVF (blue arrows). (B) Similar trends were present for a
more basal coupling of the LV posterior fascicular branch in precordial leads V5 and V6 (red arrows). Variability in LV stimulation also resulted in
notched QRS complexes in precordial and limb leads (black arrows). (C) QRS complexes of two healthy individuals in the PTB Diagnostic ECG
Database8 (subjects 237 and 117, respectively), exhibiting similar QRS features. Simulated and clinical ECG grid resolutions: 40 ms/0.1 mV.
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Figure 6 Hemiblock of the LV human conduction system. (A) Knockout of the LV anterior branch resulted in the late activation of the LV basal
free wall, moving the positive pole in body surface potentials from the left hip to the centre of the back, and recovering the clinical manifestations of
left anterior fascicular block (LAFB). (B) Similarly, LV posterior wall stimulation knockout resulted in delayed LV basal paraseptal activation, affecting
the time course and position of the negative pole in the front of the torso, with the associated clinical manifestations of left posterior fascicular block
(LPFB). Representative ECGs of LAFB and LPFB are reproduced with permission from Elizari et al.9 ECG grid resolutions: 40 ms/0.1 mV (simulation);
200 ms/0.5 mV (clinical).
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precordial derivations. Whereas insights in S-wave progression could
be used to further particularize patient-specific activation sequences,
it is important to remark that the notched QRS complexes occurred
in the absence of structural defects in the ventricles, in spite of their
frequent association. Finally, variability in the number of activation
sites recovered the pathological landmarks introduced by disease in
the human conduction system in the QRS complex, both under par-
tial and complete bundle block conditions.
Different modelling approaches have been used to date to study
the ventricular activation sequence on the human ECG. These vary in
generality, from specifying activation times analytically by means of a
parameterized sequence,15 to the creation of idealized Purkinje net-
works including explicit Purkinje-muscle junctions.16,17 They also dif-
fer in computational complexity, from the semi-automatic generation
of activation profiles,10,18 to more iterative and interactive parame-
trization processes to converge on a personalized activation se-
quence.16 The activation sequences utilized here encapsulate the
minimal information needed to investigate the implication on the
QRS complex of anatomical variability in the human trifascicular con-
duction system. This allows for an accurate, robust, and efficient
simulation of the human QRS complex, requiring minimum user input
beyond the specification of Purkinje-branch end points.
Compared to previous studies, our work represents a detailed in-
vestigation on how variability at the conduction level (progression of
the activation sequence, passive tissue conductivities, and anatomical
location of Purkinje-myocardial coupling) impacts the variability
observed at the human QRS complex. Although in this work we have
explicitly concentrated our investigations in exploring variability at
the tissue level, the tools presented here could be easily combined
with experimentally-calibrated populations of models to capture
human variability at the cellular electrophysiological level.12 This may
considerably advance the field of computational cardiac electrophysi-
ology towards a more predictive technology for risk assessment at
the population level, as both variability in conduction and cellular
electrophysiology modulate individual responses to pharmacological
and electrical therapy.
An accurate modelling of pathological conditions of the human ac-
tivation system might also yield a better understanding of clinical
ECG biomarkers of disease. Our activation sequences have been
shown to replicate the main diagnostic manifestations of left anterior
fascicular, left posterior fascicular, left bundle branch and right bundle
branch block conditions. Previous computational studies have also
shown agreement in diseased QRS biomarkers associated to left bun-
dle branch block, using either a similar modelling approach to ours
for the human activation sequence,18 or more detailed anatomical
representations of the human Purkinje network.16 Sahli et al.17 also
addressed the modelling of right bundle branch block using detailed
Purkinje trees, however, without probing its impact on the precordial
leads, which are the derivations used in its clinical diagnosis. To the
best of our knowledge, modelling of fascicular hemiblocks on the
human QRS complex has not been previously addressed in the litera-
ture. The adoption of the activation sequences proposed here could
Figure 7 Bundle branch block of the human conduction system. (A) A lateral progression of activation in LV due to the simultaneous knockout of
the LV anterior/posterior branches closely mimics the diagnostic criteria of left bundle branch block (LBBB) in precordial leads V1–V6. (B) Similar re-
sults for lateral progression of activation in RV, associated with right bundle branch block (RBBB). QRS complexes of LBBB and RBBB patients in the
PTB Diagnostic ECG Database8 (subjects 208 and 209, respectively) are provided for comparison. Clinical and simulated ECG grids resolution:
40 ms/0.1 mV.
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therefore also promote the computational modelling of other patho-
logical conditions (myocardial infarction, ischaemia, heart failure, car-
diomyopathies), frequently affected by comorbidities in the human
conduction system.
Variability in the location of activation sites from our baseline con-
figuration had only a small influence on the QRS axis. This may ex-
plain the preponderance of a QRS axis around 60 in healthy
individuals, as reflected by the PTB Diagnostic ECG Database8 where
65% (33/51) of the healthy cohort was classified as having QRS axis
between 30 and 70. It is known that a vertical heart orientation
(tall, thin individuals) is manifested in a right QRS axis shift, whilst a
left QRS axis is exhibited under more horizontal heart orientations
(short, broad individuals).9 The simulation results, therefore, reveal
that the location of stimulation sites and the rest of varied parameters
cannot explain the large variability in the healthy QRS axis observed
clinically. Therefore, other factors such as the relative orientation of
the human heart within the thoracic cavity, ventricular mass and
torso geometry might be the main determinants of variability in the
healthy human QRS complex.19 Testing of these hypotheses would
require the expensive generation of new heart-torso anatomical
models with variable heart and torso volumes and ventricular orien-
tation, and will therefore be addressed in future investigations.
Corrections to account for this geometrical variability have been pro-
posed,19 which will also be investigated in future work.
The activation sequences presented here have been shown to be a
feasible approach to capture the main intraventricular conduction de-
fects of the human conduction system. However, their underlying
simplifications may limit their applicability to model other patho-
physiological contributions of the Purkinje system.20 This may include
ventricular extrasystoles arising from Purkinje fibres in idiopathic
intrafascicular tachycardia, or retrograde propagation through the
Purkinje network. Whereas the former could a priori be easily ad-
dressed by timing additional ectopic foci in conjunction with the de-
fault activation sequence, the latter is likely to require a full coupling
of the ventricles with a detailed anatomical representation of the
Purkinje system. In addition, our results have not been compared
against those obtained by using more detailed anatomical representa-
tions of the Purkinje system, due to the lack of high-resolution data in
human in which to build such models. This may constitute an interest-
ing line of future research shall the experimental data in human be-
comes available, as well as an in-depth comparison against different
tissue descriptions of myocardial conduction.
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